InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001062993-24-018333 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-05 2024-11-01 TECH Hippel James CFO M - OptEx $0.00 +13.2K 113.1K +13% $0
D 2024-11-05 2024-11-01 TECH Hippel James CFO F - Tax $75.31 -6,475 106.6K -6% -$487.6K
D 2024-11-05 2024-11-01 TECH Hippel James CFO M - OptEx $0.00 -13.2K 13.2K -50% $0
D 2024-11-05 2024-11-01 TECH Hippel James CFO A - Grant $0.00 +34.6K 34.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-01 M A 13,159 $0.00 113,085 D — —
2 Common Common Stock 2024-11-01 F D 6,475 $75.31 106,610 D — —
3 Derivative Restricted Stock Units 2024-11-01 M D 13,159 $0.00 13,159 D — · — to — 13,159 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F8) On 11/1/2024, the Board of Directors certified vesting of ____ performance RSUs. The remaining 13,159 restricted stock units vest on 11/1/2025.
4 Derivative Restricted Stock Units 2024-11-01 A A 34,634 $0.00 34,634 D — · — to — 34,634 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F12) 11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.